Literature DB >> 26310918

Chemical Disruption of Wnt-dependent Cell Fate Decision-making Mechanisms in Cancer and Regenerative Medicine.

L Lum, C Chen1.   

Abstract

Cell-to-cell signaling molecules such as the Wnt proteins that directly influence the expression of cell-type specific transcriptional programs are essential for tissue generation in metazoans. The mechanisms supporting cellular responses to these molecules represent potential points of intervention for directing cell fate outcomes in therapeutic contexts. Small molecules that modulate Wnt-mediated cellular responses have proven to be powerful probes for Wnt protein function in diverse biological settings including cancer, development, and regeneration. Whereas efforts to develop these chemicals as therapeutic agents have dominated conversation, the unprecedented modes-of-action associated with these molecules and their implications for drug development deserve greater examination. In this review, we will discuss how medicinal chemistry efforts focused on first in class small molecules targeting two Wnt pathway components--the polytopic Porcupine (Porcn) acyltransferase and the cytoplasmic Tankyrase (Tnks) poly-ADP-ribosylases--have contributed to our understanding of the druggable genome and expanded the armamentarium of chemicals that can be used to influence cell fate decision-making.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26310918      PMCID: PMC4697282          DOI: 10.2174/0929867322666150827094015

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  90 in total

Review 1.  Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases.

Authors:  Hua Zhu Ke; William G Richards; Xiaodong Li; Michael S Ominsky
Journal:  Endocr Rev       Date:  2012-06-20       Impact factor: 19.871

2.  Wntless functions in mature osteoblasts to regulate bone mass.

Authors:  Zhendong Zhong; Cassandra R Zylstra-Diegel; Cassie A Schumacher; Jacob J Baker; April C Carpenter; Sujata Rao; Wei Yao; Min Guan; Jill A Helms; Nancy E Lane; Richard A Lang; Bart O Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-28       Impact factor: 11.205

Review 3.  Wnt signaling in bone development and disease: making stronger bone with Wnts.

Authors:  Jean B Regard; Zhendong Zhong; Bart O Williams; Yingzi Yang
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

Review 4.  Targeting Wnt pathways in disease.

Authors:  Zachary F Zimmerman; Randall T Moon; Andy J Chien
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

Review 5.  TCF/LEFs and Wnt signaling in the nucleus.

Authors:  Ken M Cadigan; Marian L Waterman
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

6.  Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors.

Authors:  Bon-Kyoung Koo; Maureen Spit; Ingrid Jordens; Teck Y Low; Daniel E Stange; Marc van de Wetering; Johan H van Es; Shabaz Mohammed; Albert J R Heck; Madelon M Maurice; Hans Clevers
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

7.  Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions.

Authors:  Xiaojun Lian; Jianhua Zhang; Samira M Azarin; Kexian Zhu; Laurie B Hazeltine; Xiaoping Bao; Cheston Hsiao; Timothy J Kamp; Sean P Palecek
Journal:  Nat Protoc       Date:  2012-12-20       Impact factor: 13.491

8.  Endogenous Wnt signalling in human embryonic stem cells generates an equilibrium of distinct lineage-specified progenitors.

Authors:  Timothy A Blauwkamp; Shelly Nigam; Reza Ardehali; Irving L Weissman; Roel Nusse
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 9.  Tankyrase-targeted therapeutics: expanding opportunities in the PARP family.

Authors:  Jenna L Riffell; Christopher J Lord; Alan Ashworth
Journal:  Nat Rev Drug Discov       Date:  2012-12       Impact factor: 84.694

10.  Precise regulation of porcupine activity is required for physiological Wnt signaling.

Authors:  Kyle D Proffitt; David M Virshup
Journal:  J Biol Chem       Date:  2012-08-10       Impact factor: 5.157

View more
  10 in total

1.  Development of a triazole class of highly potent Porcn inhibitors.

Authors:  Lin You; Chengwei Zhang; Nageswari Yarravarapu; Lorraine Morlock; Xiaolei Wang; Lishu Zhang; Noelle S Williams; Lawrence Lum; Chuo Chen
Journal:  Bioorg Med Chem Lett       Date:  2016-11-11       Impact factor: 2.823

2.  Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype.

Authors:  Robert A Mook; Jiangbo Wang; Xiu-Rong Ren; Hailan Piao; H Kim Lyerly; Wei Chen
Journal:  Bioorg Med Chem Lett       Date:  2018-11-12       Impact factor: 2.823

3.  Delivery of the Porcupine Inhibitor WNT974 in Mice.

Authors:  Li-Shu Zhang; Lawrence Lum
Journal:  Methods Mol Biol       Date:  2016

4.  Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist.

Authors:  Jesung Moon; Huanyu Zhou; Li-Shu Zhang; Wei Tan; Ying Liu; Shanrong Zhang; Lorraine K Morlock; Xiaoping Bao; Sean P Palecek; Jian Q Feng; Noelle S Williams; James F Amatruda; Eric N Olson; Rhonda Bassel-Duby; Lawrence Lum
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-31       Impact factor: 11.205

5.  Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.

Authors:  Jiaoyuan Jia; Yu Qiao; Maria G Pilo; Antonio Cigliano; Xianqiong Liu; Zixuan Shao; Diego F Calvisi; Xin Chen
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

6.  Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9.

Authors:  Li-Shu Zhang; Xunlei Kang; Jianming Lu; Yuannyu Zhang; Xiaofeng Wu; Guojin Wu; Junke Zheng; Rubina Tuladhar; Heping Shi; Qiaoling Wang; Lorraine Morlock; Huiyu Yao; Lily Jun-Shen Huang; Pascal Maire; James Kim; Noelle Williams; Jian Xu; Chuo Chen; Cheng Cheng Zhang; Lawrence Lum
Journal:  EBioMedicine       Date:  2018-12-06       Impact factor: 8.143

7.  Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.

Authors:  Wenhui Wang; Pengyu Liu; Marla Lavrijsen; Shan Li; Ruyi Zhang; Shanshan Li; Wesley S van de Geer; Harmen J G van de Werken; Maikel P Peppelenbosch; Ron Smits
Journal:  Sci Rep       Date:  2021-04-02       Impact factor: 4.379

8.  Modeling Intercellular Communication as a Survival Strategy of Cancer Cells: An In Silico Approach on a Flexible Bioinformatics Framework.

Authors:  Maura Cárdenas-García; Pedro P González-Pérez; Sara Montagna; Oscar Sánchez Cortés; Elena Hernández Caballero
Journal:  Bioinform Biol Insights       Date:  2016-03-13

9.  ERAD-dependent control of the Wnt secretory factor Evi.

Authors:  Kathrin Glaeser; Manuela Urban; Emma Fenech; Oksana Voloshanenko; Dominique Kranz; Federica Lari; John C Christianson; Michael Boutros
Journal:  EMBO J       Date:  2018-01-29       Impact factor: 11.598

10.  Wnt signaling regulates trans-differentiation of stem cell like type 2 alveolar epithelial cells to type 1 epithelial cells.

Authors:  Elhusseiny Mohamed Mahmud Abdelwahab; Judit Rapp; Diana Feller; Veronika Csongei; Szilard Pal; Domokos Bartis; David R Thickett; Judit Erzsebet Pongracz
Journal:  Respir Res       Date:  2019-09-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.